Coordinatore | ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Organization address
address: Via Giuseppe La Masa 19 contact info |
Nazionalità Coordinatore | Italy [IT] |
Sito del progetto | http://www.ecranproject.eu |
Totale costo | 970˙625 € |
EC contributo | 892˙666 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2012-INNOVATION-1 |
Funding Scheme | CSA-CA |
Anno di inizio | 2012 |
Periodo (anno-mese-giorno) | 2012-09-01 - 2014-08-31 |
# | ||||
---|---|---|---|---|
1 |
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Organization address
address: Via Giuseppe La Masa 19 contact info |
IT (MILANO) | coordinator | 295˙764.00 |
2 |
ZADIG SRL
Organization address
address: VIA AMPERE ANDREA MARIA 59 contact info |
IT (MILANO) | participant | 182˙362.00 |
3 |
REGION HOVEDSTADEN
Organization address
address: KONGENS VAENGE 2 contact info |
DK (HILLEROD) | participant | 173˙420.00 |
4 |
THE COCHRANE COLLABORATION LBG
Organization address
address: SUMMERTOWN PAVILION 18-24 MIDDLE contact info |
UK (OXFORD) | participant | 116˙630.00 |
5 |
EUROPEAN AIDS TREATMENT GROUP EV
Organization address
address: METTMANNER STRASSE 24-26 contact info |
DE (DUSSELDORF) | participant | 25˙680.00 |
6 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | participant | 25˙680.00 |
7 |
KLINIKUM DER UNIVERSITAET ZU KOELN
Organization address
address: Kerpener Strasse 62 contact info |
DE (KOELN) | participant | 25˙680.00 |
8 |
UNIVERSITAETSKLINIKUM FREIBURG
Organization address
address: HUGSTETTER STRASSE 49 contact info |
DE (FREIBURG) | participant | 25˙680.00 |
9 |
Oxford Radcliffe Hospitals NHS Trust
Organization address
address: "Headley Way, Headington" contact info |
UK (Oxford) | participant | 21˙770.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'The ECRAN (European Communication on Research Awareness Needs) project is designed to develop a portfolio of open educational resources, including a film, for the general population about the challenges raised by independent clinical research. The European Commission (FP7 Health Priority) decided to allocate substantial funding to independent (investigator-driven) clinical trials. Together with member states, the FP7 infrastructure unit supports the preparation and operation of a pan-European infrastructure for clinical trials (ECRIN). Through these instruments, Europe has the capacity to design and conduct independent, multinational clinical trials. The objective of the ECRAN project is to develop tools to communicate key messages to citizens, patients, healthcare professionals, researchers, policymakers and society about independent, multinational clinical research. These messages will focus on: i) the importance of public understanding of the need for and basic principles of clinical trials, fostering active involvement of patients in trials and of their representatives in trial design; ii) the need for independent clinical trials driven by healthcare issues, to optimise treatment strategies through comparison of benefits and harms of multiple therapeutic options, supporting evidence-based clinical practice and reduction in healthcare inequalities; iii) the need for transparency and optimal use of data, to promote the cost-effectiveness of treatments and to reduce the economic burden of diseases; iv) the need for multinational cooperation, taking advantage of Europe’s population size and diversity, and of its medical expertise. These objectives will be addressed using communication tools, including: a website, with an online database of open educational resources in different European languages; a film on clinical trials, dubbed in many languages, which is envisaged as a keystone of this initiative; an international event on multinational clinical trials.'
An online resource for the latest advances in medical research will empower Europeans to make better choices about their health, providing them with opportunities to participate in clinical trials.